Works matching IS 09509232 AND DT 2010 AND VI 29 AND IP 27

Results: 11

The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status.
Published in:
Oncogene, 2010, v. 29, n. 27, p. 3990, doi. 10.1038/onc.2010.137
By:
- Kim, M.;
- Williamson, C. T.;
- Prudhomme, J.;
- Bebb, D. G.;
- Riabowol, K.;
- Lee, P. W. K.;
- Lees-Miller, S. P.;
- Mori, Y.;
- Rahman, M. M.;
- McFadden, G.;
- Johnston, R. N.
Publication type:
Article
DNA breakage and cell cycle checkpoint abrogation induced by a therapeutic thiopurine and UVA radiation.
Published in:
Oncogene, 2010, v. 29, n. 27, p. 3953, doi. 10.1038/onc.2010.140
By:
- Brem, R.;
- Li, F.;
- Montaner, B.;
- Reelfs, O.;
- Karran, P.
Publication type:
Article
Cancer-selective apoptotic effects of extracellular and intracellular Par-4.
Published in:
Oncogene, 2010, v. 29, n. 27, p. 3873, doi. 10.1038/onc.2010.141
By:
- Shrestha-Bhattarai, T.;
- Rangnekar, V. M.
Publication type:
Article
Homeobox gene IRX1 is a tumor suppressor gene in gastric carcinoma.
Published in:
Oncogene, 2010, v. 29, n. 27, p. 3908, doi. 10.1038/onc.2010.143
By:
- Guo, X.;
- Liu, W.;
- Pan, Y.;
- Ni, P.;
- Ji, J.;
- Guo, L.;
- Zhang, J.;
- Wu, J.;
- Jiang, J.;
- Chen, X.;
- Cai, Q.;
- Li, J.;
- Gu, Q.;
- Liu, B.;
- Zhu, Z.;
- Yu, Y.
Publication type:
Article
The interplay between Eps8 and IRSp53 contributes to Src-mediated transformation.
Published in:
Oncogene, 2010, v. 29, n. 27, p. 3977, doi. 10.1038/onc.2010.144
By:
- Liu, P.-S.;
- Jong, T.-H.;
- Maa, M.-C.;
- Leu, T.-H.
Publication type:
Article
p21 Downregulation is an important component of PAX3/FKHR oncogenicity and its reactivation by HDAC inhibitors enhances combination treatment.
Published in:
Oncogene, 2010, v. 29, n. 27, p. 3942, doi. 10.1038/onc.2010.145
By:
- Hecker, R. M.;
- Amstutz, R. A.;
- Wachtel, M.;
- Walter, D.;
- Niggli, F. K.;
- Schäfer, B. W.
Publication type:
Article
Mitochondrial pyrimidine nucleotide carrier (PNC1) regulates mitochondrial biogenesis and the invasive phenotype of cancer cells.
Published in:
Oncogene, 2010, v. 29, n. 27, p. 3964, doi. 10.1038/onc.2010.146
By:
- Favre, C.;
- Zhdanov, A.;
- Leahy, M.;
- Papkovsky, D.;
- O'Connor, R.
Publication type:
Article
A novel interaction between HER2/neu and cyclin E in breast cancer.
Published in:
Oncogene, 2010, v. 29, n. 27, p. 3896, doi. 10.1038/onc.2010.151
By:
- Mittendorf, E. A.;
- Liu, Y.;
- Tucker, S. L.;
- McKenzie, T.;
- Qiao, N.;
- Akli, S.;
- Biernacka, A.;
- Meijer, L.;
- Keyomarsi, K.;
- Hunt, K. K.
Publication type:
Article
PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage.
Published in:
Oncogene, 2010, v. 29, n. 27, p. 3881, doi. 10.1038/onc.2010.153
By:
- Bobrovnikova-Marjon, E.;
- Grigoriadou, C.;
- Pytel, D.;
- Zhang, F.;
- Ye, J.;
- Koumenis, C.;
- Cavener, D.;
- Diehl, J. A.
Publication type:
Article
Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion.
Published in:
Oncogene, 2010, v. 29, n. 27, p. 3921, doi. 10.1038/onc.2010.158
By:
- Santhanam, A. N.;
- Baker, A. R.;
- Hegamyer, G.;
- Kirschmann, D. A.;
- Colburn, N. H.
Publication type:
Article
A B56γ mutation in lung cancer disrupts the p53-dependent tumor-suppressor function of protein phosphatase 2A.
Published in:
Oncogene, 2010, v. 29, n. 27, p. 3933, doi. 10.1038/onc.2010.161
By:
- Shouse, G. P.;
- Nobumori, Y.;
- Liu, X.
Publication type:
Article